Nagsen Gautam
Arrowhead Pharmaceuticals (United States)
ORCID: 0000-0001-5876-6760Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation”.
Brady Sillman, Aditya N. Bade, Sean N. Avedissian, Anthony T. Podany, JoEllyn McMillan +18 more
Nathan Smith, Suyash Deodhar, Aditya N. Bade, Nagsen Gautam, Bhagya Laxmi Dyavar Shetty +6 more
JoEllyn McMillan, Devendra Kumar, Aditya N. Bade, Qiaoyu Pan, Tanmay A. Kulkarni +9 more
Sushil Kumar, Nagsen Gautam, Anthony T. Podany, Lee C. Winchester, Jonathan A. Weinhold +5 more
Lauren Lesiak, Christopher D. Aretz, Yu Du, Sushil Kumar, Nagsen Gautam +6 more
Nagsen Gautam, Yazen Alnouti, Devendra Kumar
Satish Sagar, Sydney P. Kubica, Lidia Boghean, Smit Kour, Hannah M. King +19 more
Surendra K. Shukla, Asserewou Etekpo, Venugopal Gunda, Sharalyn Steenson, Nagsen Gautam +3 more
Brady Sillman, Aditya N. Bade, JoEllyn McMillan, Nagsen Gautam, Brandon Hanson +15 more
Gang Zhao, Xiaobei Wang, Nagsen Gautam, Zhenshan Jia, Zhifeng Zhao +14 more